Erstellt von conna
Amgen Inc. diskutieren
Amgen Inc.
WKN: 867900 / Symbol: AMGN / Name: Amgen / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
300,20 €
0,18 %
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Argus from $310.00 to $360.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $330.00 to $335.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $400.00 to $403.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) was given a new $400.00 price target on by analysts at Oppenheimer Holdings, Inc.. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Leerink Partners from $305.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $403.00 to $415.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $335.00 to $360.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Argus from $360.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Daiwa Securities Group Inc. from $370.00 to $410.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Rothschild & Co Redburn from $180.00 to $200.00. They now have a "sell" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its price target raised by Royal Bank Of Canada from $360.00 to $370.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its price target raised by UBS Group AG from $390.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its price target raised by The Goldman Sachs Group, Inc. from $415.00 to $425.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its price target lowered by Daiwa Securities Group Inc. from $410.00 to $390.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its price target lowered by Argus from $400.00 to $375.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its "overweight" rating reaffirmed by Piper Sandler.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) was upgraded by Wall Street Zen from "hold" to "buy".
Ratings data for AMGN provided by MarketBeat
Neueste Beiträge
Barrington_Research in Synnex Corp. diskutieren